J.W. Cole Advisors’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $431K | Sell |
19,981
-3,045
| -13% | -$65.7K | 0.01% | 970 |
|
|
2025
Q1 | $382K | Buy |
23,026
+5,406
| +31% | +$89.8K | 0.01% | 861 |
|
|
2024
Q4 | $323K | Hold |
17,620
| – | – | 0.01% | 755 |
|
|
2024
Q3 | $271K | Hold |
17,620
| – | – | 0.01% | 809 |
|
|
2024
Q2 | $286K | Hold |
17,620
| – | – | 0.01% | 718 |
|
|
2024
Q1 | $326K | Hold |
17,620
| – | – | 0.02% | 664 |
|
|
2023
Q4 | $552K | Hold |
17,620
| – | – | 0.03% | 458 |
|
|
2023
Q3 | $367K | Sell |
17,620
-265
| -1% | -$5.52K | 0.03% | 503 |
|
|
2023
Q2 | $428K | Hold |
17,885
| – | – | 0.03% | 463 |
|
|
2023
Q1 | $337K | Hold |
17,885
| – | – | 0.02% | 564 |
|
|
2022
Q4 | $285K | Hold |
17,885
| – | – | 0.02% | 578 |
|
|
2022
Q3 | $293K | Hold |
17,885
| – | – | 0.02% | 543 |
|
|
2022
Q2 | $252K | Sell |
17,885
-25
| -0.1% | -$352 | 0.02% | 599 |
|
|
2022
Q1 | $434K | Hold |
17,910
| – | – | 0.03% | 497 |
|
|
2021
Q4 | $418K | Hold |
17,910
| – | – | 0.03% | 532 |
|
|
2021
Q3 | $297K | Hold |
17,910
| – | – | 0.02% | 359 |
|
|
2021
Q2 | $437K | Buy |
17,910
+25
| +0.1% | +$610 | 0.03% | 468 |
|
|
2021
Q1 | $461K | Sell |
17,885
-544
| -3% | -$14K | 0.04% | 403 |
|
|
2020
Q4 | $985K | Sell |
18,429
-775
| -4% | -$41.4K | 0.1% | 225 |
|
|
2020
Q3 | $792K | Buy |
19,204
+1,284
| +7% | +$53K | 0.06% | 305 |
|
|
2020
Q2 | $869K | Buy |
+17,920
| New | +$869K | 0.13% | 176 |
|
|
2020
Q1 | – | Sell |
-22,042
| Closed | -$943K | – | 103 |
|
|
2019
Q4 | $943K | Buy |
+22,042
| New | +$943K | 0.12% | 196 |
|